![Shenzhen Salubris Pharmaceuticals Co., Ltd. logo](/logos/002294.SZ.webp)
Shenzhen Salubris Pharmaceuticals Co., Ltd.
SZSE:002294.SZ
Overview | Financials
Company Name | Shenzhen Salubris Pharmaceuticals Co., Ltd. |
Symbol | 002294.SZ |
Currency | CNY |
Price | 29.64 |
Market Cap | 33,043,263,852 |
Dividend Yield | 0% |
52-week-range | 25.58 - 39.33 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Jie Yan |
Website | https://www.salubris.com |
An error occurred while fetching data.
About Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD